Adam Lauver

Adam Lauver, PhD, is an Associate Professor in the Department of Pharmacology and Toxicology at Michigan State University, affiliated with the College of Veterinary Medicine. His research focuses on cardiovascular pharmacology, drug discovery, and pharmacokinetics, particularly investigating antiplatelet therapies like clopidogrel and novel drug candidates for cardiovascular and infectious diseases. As director of the MSU Certara Center of Excellence, he integrates computational modeling with experimental methods to advance drug development.

Education:

• Postdoctoral Training: Pharmacology, University of Michigan (2007–2011)
• PhD: Pharmacology, University of Michigan (2002–2007)
• Bachelor of Science: Pennsylvania State University (1997–2001)

Research Interests: His work explores vascular effects of antiplatelet agents, drug discovery for cardiovascular diseases, and the role of perivascular adipose tissue (PVAT) in hypertension and arrhythmias. Collaborations with industry and NIH-funded projects drive translational pharmacology.

Publications: Recent work emphasizes QT interval analysis, clopidogrel mechanisms, and PVAT's role in vascular health. Key themes include drug safety, cardiovascular modeling, and therapeutic optimization.

Funding: Active NIH grant (2021–2026) supports studies on PVAT as a central integrator of vascular health under high-fat diets and hypertension.

Lab & Teams: Lab staff includes Barbara Christian. Mentees include Afolashade Onunkun and Kamila Sadko. The lab collaborates on projects involving computational modeling and translational research.